全关节置换术后常规化学检查并非必要
本研究回顾2015至2017年3162例患者共3721例全关节置换术,分析术后常规化学七项异常的发生率、危险因素及临床干预。结果显示术前异常、双侧置换、肾病及利尿剂使用是术后异常预测因素,电解质相关干预率低,建议选择性检查而非常规。
要点
- 术前化学异常是术后异常的重要预测因素。
- 双侧置换增加术后钠异常风险,肾病增加肌酐异常风险。
- 电解质相关干预率低,支持选择性检查策略。
核心结论
- 对于大多数全关节置换患者,常规术后化学七项检查并非必要。
- 建议对术前化学异常、肾病、双侧置换及使用ACEI/ARB/利尿剂的患者进行术后化学七项检查。
研究设计与样本
- 回顾性队列研究,纳入2015至2017年3162例患者共3721例全关节置换术。
- 采用混合效应多因素逻辑回归分析术后化学异常的危险因素。
主要发现
- 术后低钾发生率9.7%,高钠25.6%,血尿素氮异常55.6%,肌酐异常27.9%。
- 术前钠异常预测术后钠异常OR=2.15(95%CI 1.82-2.54)。
- 术前钾异常预测术后钾异常OR=4.22(95%CI 3.03-5.88)。
- 术前肌酐异常预测术后肌酐异常OR=3.00(95%CI 2.45-3.68)。
- 双侧置换与术后钠异常相关OR=1.56(95%CI 1.44-1.68)。
关键数值与推荐
- 6.7%的低钾患者接受了氯化钾液体/片剂治疗。
- 40%的低钠患者接受了氯化钠液体/片剂治疗。
- 电解质相关内科会诊率为0.3%(13/3721)。
临床怎么用
- 对术前化学异常、肾病、双侧置换及使用ACEI/ARB/利尿剂的患者进行术后化学七项检查。
- 避免对所有全关节置换患者常规进行术后化学七项检查。
局限性
- 回顾性研究设计,证据等级为预后Level IV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The routine use of traditional chemistry-7 (chem-7) laboratory tests following total joint arthroplasty (TJA) has been called into question with the advent of short-stay procedures. Our objective was to determine the incidence, risk factors, and clinical interventions associated with inpatient abnormal routine postoperative chem-7 panels. METHODS: From 2015 to 2017, 3,162 patients underwent a total of 3,721 TJA procedures, including primary total hip arthroplasty (THA) (n = 1,939; 52.1%) or primary total knee arthroplasty (TKA) (n = 1,782; 47.9%). Patients underwent routine preoperative and postoperative chem-7 testing. Clinical interventions were identified. With use of mixed-effects multivariate logistic regression, potential risk factors for abnormal chemistry panel values (including preoperative chem-7 results, type of surgery, age, sex, race, comorbidities, American Society of Anesthesiologists [ASA] score, and medications) were analyzed. RESULTS: The rates of abnormal preoperative laboratory results were 3.4% for sodium (Na+), 7.4% for potassium (K+), 15.8% for blood urea nitrogen (BUN), and 26.4% for creatinine (Cr). The incidence of abnormal postoperative results was low for K+ (9.7%) and higher for Na+ (25.6%), BUN (55.6%), and Cr (27.9%). Preoperative abnormal laboratory results were a significant predictor of a postoperative abnormality for Na+ (odds ratio [OR] = 2.15; 95% confidence interval [CI] = 1.82 to 2.54), K+ (OR = 4.22; 95% CI = 3.03 to 5.88), and Cr (OR = 3.00; 95% CI = 2.45 to 3.68). Bilateral TJA was associated with increased odds of abnormal postoperative Na+ (OR = 1.56; 95% CI = 1.44 to 1.68). Renal disease was associated with increased odds of abnormal postoperative Cr (OR = 15.21; 95% CI = 5.67 to 40.77). Patients taking loop diuretics had increased odds of abnormal postoperative K+ (OR = 2.10; 95% CI = 1.42 to 3.11) and Cr (OR = 2.28; 95% CI = 1.56 to 3.33). Regarding intervention, 6.7% of hypokalemic patients received potassium chloride (KCl) fluid/tablets. Forty percent of hyponatremic patients received sodium chloride (NaCl) fluid/tablets. The electrolyte-related medicine consultation rate was 0.3% (13 of 3,721). CONCLUSIONS: On the basis of our findings, we recommend postoperative chem-7 testing for patients with an abnormal preoperative laboratory result (Na+, K+, BUN, Cr), preexisting renal disease, bilateral TJA, and prescribed angiotensin-converting enzyme inhibitors (ACE), angiotensin II receptor blockers (ARB), and diuretics. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Tischler EH, Restrepo C, Ponzio DY, et al. Routine Postoperative Chemistry Panels Are Not Necessary for Most Total Joint Arthroplasty Patients. J Bone Joint Surg Am. 2021. PMID: 34038395. doi:10.2106/JBJS.20.01530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。